/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
TSX-V: GGG, OTCQB: GPHBF
VANCOUVER and NEW YORK, Dec. 11, 2015 /CNW/ - Graphene 3D Lab Inc. (TSXV: GGG) ("Graphene 3D" or the "Company") announced on December 10, 2015 that it has arranged a non-brokered private placement of up to 3,400,000 units (collectively, the "Units") at CND$0.25 per Unit to raise up to CND$850,000 in gross proceeds. Graphene 3D is pleased to announce that it has increased the proposed private placement to up to 4,000,000 Units to raise up to CDN$1,000,000 in gross proceeds. Each Unit will consist of one common share and one non-transferable share purchase warrant (collectively, the "Warrants"). Each Warrant will entitle the holder to purchase one additional common share of Graphene 3D at a price of CND$0.30 per share for a period of two years from the closing date. Graphene 3D may pay a cash finder's fee equal to 7% of the gross proceeds raised in connection with the financing to arm's length finders in accordance with the policies of the TSX Venture Exchange.
Completion of this financing is subject to the delivery of definitive subscription agreements and TSX Venture Exchange's acceptance. All of the securities issued pursuant to this offering will have a hold period expiring four months and a day after the closing date.
Proceeds of this financing will be used primarily for expansion of the Company's business and for general working capital purposes.
About Graphene 3D
Graphene 3D is BC company whose common shares are listed on the TSX Venture Exchange, which now owns all of the issued and outstanding shares of Graphene 3D Lab (U.S.) Inc., a private Delaware corporation, organized on September 3, 2013 ("Graphene US"). Graphene US is in the business of developing, manufacturing, and marketing proprietary polymer nanocomposite graphene-based materials for various types of 3D printing, including fused filament fabrication as well as the design, manufacture and marketing of three-dimensional printers and products for worldwide customers, including in the aerospace and automotive industries, manufacturers of medical prosthetics and the military. Graphene US currently has six US patent applications pending for its technology. For more information on Graphene 3D Lab Inc., visit www.graphene3dlab.com.
FORWARD LOOKING INFORMATION
THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS PRESS RELEASE REPRESENTS THE EXPECTATIONS OF THE COMPANY AS OF THE DATE OF THIS PRESS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
SOURCE Graphene 3D Lab Inc.
For further information: Commercial Inquiries: Daniel Stolyarov, Co-Chief Executive Officer, Telephone: (631) 405-5116, Email: daniel.stolyarov@graphene3Dlab.com; Investor Inquiries: Paul Thomson, Investor Relations Coordinator, Telephone (631) 405-5114, Email: investors@graphene3Dlab.com